In stratification by DOAC type, risk associated with the P‐gp/CYP3A4 inhibitors group was statistically significant in rivaroxaban users and borderline significant for dabigatran.
← all excerpts
Association Between Use of Pharmacokinetic-Interacting Drugs and Effectiveness and Safety of Direct Acting Oral Anticoagulants: Nested Case-Control Study.
1
—
—